- Home
- Publications
- Publication Search
- Publication Details
Title
Psoriasis
Authors
Keywords
-
Journal
LANCET
Volume 397, Issue 10281, Pages 1301-1315
Publisher
Elsevier BV
Online
2021-04-02
DOI
10.1016/s0140-6736(20)32549-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
- (2020) G. Caldarola et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis
- (2020) Silke Frey et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020 – a rapid update
- (2020) C.H. Smith et al. BRITISH JOURNAL OF DERMATOLOGY
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic
- (2020) Marilyn T. Wan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease
- (2020) Marta Vergnano et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
- (2020) Stefan Haskamp et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study
- (2020) Satveer K. Mahil et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study
- (2019) Ashley Budu-Aggrey et al. PLOS MEDICINE
- Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
- (2019) Uchenna Agbim et al. Expert Review of Gastroenterology & Hepatology
- French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults
- (2019) F. Amatore et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Women with moderate‐severe psoriasis in Spain (Biobadaderm registry) show over a 50% reduction in age‐adjusted fertility rate when compared with the general population
- (2019) A. Gonzalez‐Cantero et al. BRITISH JOURNAL OF DERMATOLOGY
- Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic
- (2019) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis treat to target: defining outcomes in psoriasis using data from a real world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
- (2019) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy
- (2019) Craig A. Elmets et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council
- (2019) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Belgian Consensus On The Definition Of A Treat‐To‐Target Outcome Set In Psoriasis Management
- (2019) Lynda Grine et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
- (2018) Jürgen Brück et al. EXPERIMENTAL DERMATOLOGY
- Clinical and genetic differences between pustular psoriasis subtypes
- (2018) Sophie Twelves et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Current developments in phototherapy for psoriasis
- (2018) Akimichi Morita JOURNAL OF DERMATOLOGY
- Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Ireny Y.K. Iskandar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study
- (2018) James Cheng-Chung Wei et al. JOURNAL OF RHEUMATOLOGY
- CME Part I Psoriasis: Which Therapy for Which Patient Psoriasis comorbidities and preferred systemic agents
- (2018) Shivani B. Kaushik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)
- (2018) Alice B. Gottlieb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Generalized pustular psoriasis: a review and update on treatment
- (2018) K.M. Hoegler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The pathogenesis of psoriatic arthritis
- (2018) Douglas J Veale et al. LANCET
- Clinical management of psoriatic arthritis
- (2018) Filip Van den Bosch et al. LANCET
- Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
- (2018) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study
- (2018) Nina Wilkinson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- (2018) Kenneth B Gordon et al. LANCET
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study
- (2018) Lihi Eder et al. ARTHRITIS CARE & RESEARCH
- HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis
- (2018) Nick Dand et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling
- (2017) Nick Dand et al. HUMAN MOLECULAR GENETICS
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
- (2017) Andrew Johnston et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Psoriasis and latitude: Analytic approaches and future data needs
- (2017) Rebecca I. Hartman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis and suicidality: A systematic review and meta-analysis
- (2017) Sanminder Singh et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
- (2017) April W. Armstrong et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Richard B Warren et al. LANCET
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Psoriatic Arthritis
- (2017) Christopher T. Ritchlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants
- (2017) Lam C. Tsoi et al. Nature Communications
- Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE)
- (2016) U. Mrowietz et al. BRITISH JOURNAL OF DERMATOLOGY
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study
- (2016) D.A. Springate et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17 Responses Are the Dominant Inflammatory Signal Linking Inverse, Erythrodermic, and Chronic Plaque Psoriasis
- (2016) Xianying Xing et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
- (2016) Eva Vilarrasa et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
- (2016) Conor M. Henry et al. Cell Reports
- Patient-relevant treatment goals in psoriasis
- (2015) Christine Blome et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
- (2015) Jamie L. Harden et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Establishing an Academic–Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy
- (2015) Christopher E.M. Griffiths et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink
- (2015) Rosa Parisi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effect of tonsillectomy on psoriasis: A systematic review
- (2015) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
- (2015) Caitriona Ryan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population-Based Study
- (2015) Anna Cantarutti et al. PEDIATRIC DERMATOLOGY
- Resident memory T cells in human health and disease
- (2015) R. A. Clark Science Translational Medicine
- Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis
- (2015) Stef P. Menting et al. JAMA Dermatology
- Induction of IL-17+ T Cell Trafficking and Development by IFN- : Mechanism and Pathological Relevance in Psoriasis
- (2014) I. Kryczek et al. JOURNAL OF IMMUNOLOGY
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis
- (2014) S. Cheuk et al. JOURNAL OF IMMUNOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A large-scale screen for coding variants predisposing to psoriasis
- (2013) Huayang Tang et al. NATURE GENETICS
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
- (2013) M. Jani et al. RHEUMATOLOGY
- Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis
- (2013) Stef P. Menting et al. JAMA Dermatology
- Familial Pityriasis Rubra Pilaris Is Caused by Mutations in CARD14
- (2012) Dana Fuchs-Telem et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives
- (2012) A.D. Burden et al. BRITISH JOURNAL OF DERMATOLOGY
- Adherence to medication in patients with psoriasis: a systematic literature review
- (2012) R.J. Thorneloe et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
- (2012) Luigi Tortola et al. JOURNAL OF CLINICAL INVESTIGATION
- Psoriatic Arthritis and Onycholysis — Results from the Cross-sectional Reykjavik Psoriatic Arthritis Study
- (2012) THORVARDUR JON LOVE et al. JOURNAL OF RHEUMATOLOGY
- Obesity, waist circumference, weight change and the risk of psoriasis in US women
- (2012) S. Kumar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study
- (2012) S. Dogra et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
- (2011) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nail psoriasis in Germany: epidemiology and burden of disease
- (2010) M. Augustin et al. BRITISH JOURNAL OF DERMATOLOGY
- Onset of psoriasis following treatment with tocilizumab
- (2010) S. Laurent et al. BRITISH JOURNAL OF DERMATOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association analyses identify six new psoriasis susceptibility loci in the Chinese population
- (2010) Liang-Dan Sun et al. NATURE GENETICS
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
- (2010) Ulrike Hüffmeier et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response
- (2009) T. Rakkhit et al. BRITISH JOURNAL OF DERMATOLOGY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Risk of Stroke in Patients with Psoriasis
- (2009) Joel M. Gelfand et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Molecular Dissection of Psoriasis: Integrating Genetics and Biology
- (2009) James T. Elder et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort
- (2009) Marlies Wakkee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Trends in incidence of adult-onset psoriasis over three decades: A population-based study
- (2009) Murat Icen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Incidence of psoriasis in children: A population-based study
- (2009) Megha M. Tollefson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
- (2008) Justin M. Ko et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
- (2008) Rajan P. Nair et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started